Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
17/06/2025
Yamato Capital has rated You Bi Xuan's initial rating as a buy.
Latest
4 m ago
Media reports that Eli Lilly & Co. is close to acquiring Verve Therapeutics for $1.3 billion, causing Verve Therapeutics' stock price to increase by 69.7% in pre-market trading to $10.6.
5 m ago
Middle East turmoil affecting LNG transportation as European natural gas prices continue to rise under threat of conflict in Iraq.
5 m ago
The S&P 500 futures fell by 0.5%, the Nasdaq 100 futures fell by 0.5%, and the Dow Jones futures fell by 0.6%.
5 m ago
The S&P 500 futures fell by 0.5%, the Nasdaq 100 futures fell by 0.5%, and the Dow Jones futures fell by 0.6%.
5 m ago
Shareholder Ningbo Yixian of Wanfeng Group (603172.SH) has completed the reduction of shares, totaling a reduction of 1.75% of shares.
See all latest
